141 results on '"Höglund, Martin"'
Search Results
2. Epidemiology of Chronic Myeloid Leukaemia
3. P506: CLINICAL VALIDATION OF THE NORDIC GUIDELINES FOR GERMLINE TESTING IN MYELOID NEOPLASMS: RESULTS FROM A MULTI-CENTER PROSPECTIVE COHORT STUDY
4. P513: MOLECULAR PATTERN BY AGE AND OVERALL SURVIVAL IN ACUTE MYELOID LEUKEMIA: A POPULATION-BASED STUDY FROM THE SWEDISH AML REGISTRY.
5. S181: THE PHASE III, RANDOMIZED COMMODORE 2 TRIAL: RESULTS FROM A MULTICENTER STUDY OF CROVALIMAB VS ECULIZUMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) PATIENTS NAIVE TO COMPLEMENT INHIBITORS
6. Next generation pan-cancer blood proteome profiling using proximity extension assay
7. Transparent Wood Biocomposite of Well-Dispersed Dye Content for Fluorescence and Lasing Applications
8. The impact of Covid-19 in patients with chronic myeloid leukemia—a nationwide population-based study
9. Supplementary Figures 1 through 3 from The Tyrosine Kinase Inhibitors Imatinib and Dasatinib Reduce Myeloid Suppressor Cells and Release Effector Lymphocyte Responses
10. Data from The Tyrosine Kinase Inhibitors Imatinib and Dasatinib Reduce Myeloid Suppressor Cells and Release Effector Lymphocyte Responses
11. Supplementary Figures 1 through 3 from The Tyrosine Kinase Inhibitors Imatinib and Dasatinib Reduce Myeloid Suppressor Cells and Release Effector Lymphocyte Responses
12. Figure S2 from A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia
13. Table S1 from A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia
14. Figure S1 from A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia
15. Table S1 from A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia
16. Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children
17. Noninvasive detection of any-stage cancer using free glycosaminoglycans
18. Plasma protein biomarker profiling reveals major differences between acute leukaemia, lymphoma patients and controls
19. IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia
20. Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications
21. Targeting SAMHD1 with hydroxyurea in first‐line cytarabine‐based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT‐AML trial
22. Cardiovascular disease in patients with chronic lymphocytic leukemia: A Swedish nationwide register study with matched comparators
23. A Study Protocol for Validation and Implementation of Whole-Genome and -Transcriptome Sequencing as a Comprehensive Precision Diagnostic Test in Acute Leukemias
24. Charge Regulated Diffusion of Silica Nanoparticles into Wood for Flame Retardant Transparent Wood
25. A risk score based on real-world data to predict early death in acute promyelocytic leukemia
26. Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow‐up of patients diagnosed 2002–2017 in a complete coverage and nationwide agnostic register study
27. Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression
28. Epidemiology of Chronic Myeloid Leukemia
29. Socioeconomic cost of AML in Sweden—A population‐based study using multiple nation‐wide registers
30. Facile Processing of Transparent Wood Nanocomposites with Structural Color from Plasmonic Nanoparticles
31. Successful tyrosine kinase inhibitor discontinuation outside clinical trials — data from the population‐based Swedish chronic myeloid leukaemia registry
32. Estimation of numbers of mature and immature neutrophils in blood by a novel, rapid and simple technology
33. Is there an impact of measurable residual disease as assessed by multiparameter flow cytometry on survival of AML patients treated in clinical practice? A population-based study
34. Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial
35. Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets
36. Impact of treatment delay in acute myeloid leukemia revisited
37. Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma
38. Clinical and genomic characterization of patients diagnosed with the provisional entity acute myeloid leukemia with BCR‐ABL1, a Swedish population‐based study
39. 853 Profiling of donor-specific immune effector signatures in response to rituximab in a human whole blood loop assay using blood from CLL patients
40. Vitamin D levels and busulphan kinetics in patients undergoing hematopoietic stem cell transplantation, a multicenter study
41. Transparent Wood Biocomposites by Fast UV-Curing for Reduced Light-Scattering through Wood/Thiol–ene Interface Design
42. Detection of leukemia gene fusions by targeted RNA-sequencing in routine diagnostics
43. Increased levels of the cardiovascular disease risk biomarkers GDF15 and myostatin in patients with chronic lymphocytic leukemia
44. The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia
45. High prevalence and incidence of cardiovascular disease in chronic lymphocytic leukaemia: a nationwide population‐based study
46. AroCell TK 210 ELISA for determination of TK1 protein: age-related reference ranges and comparison with other TK1 assays
47. The prognostic impact of FLT3-ITD and NPM1 mutation in adult AML is age-dependent in the population-based setting
48. Introducing patient‐reported outcome in the acute leukemia quality registries in Sweden
49. Real‐world data on treatment patterns and outcomes of hypomethylating therapy in patients with newly diagnosed acute myeloid leukaemia aged ≥ 60 years
50. Hypo, Hyper, or Combo: new paradigm for treatment of acute myeloid leukemia in older people
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.